As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...

Shares of ICU Medical (NASDAQ:ICUI) spiked on Friday after Piper Sandler initiated its coverage with an Overweight rating and a $145 price target, citing an imminent new product cycle wave for the ...

In trading on Wednesday, shares of ICU Medical, Inc. (NASD: ICUI) crossed above their 200 day moving average of $66.17, changing hands as high as $66.20 per share.

ICU Medical’s presentation will be on Monday, April 7, 2025 at 8:00 a.m. PT (11:00 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, April 7, 2025. The pre ...

Calling ICU Medical’s subsequent pitch the “superior transaction,” Smiths expects to receive $1.85 billion in cash plus $500 million in ICU Medical shares, equal to about 10% of its extended ...

The deal boosts the product line of ICU Medical, with a $4.4 billion market cap at press time. Like Smiths, it also focuses on developing devices or IV infusion therapy, including IV systems, ...

ICU MEDICAL, INC. AND SUBSIDIARIES Reconciliation of GAAP to Non-GAAP Financial Measures (Unaudited) (In thousands, except per share data) Adjusted EBITDA Three months endedSeptember 30, 2022 ...

ICU Medical has recalled two lots of potassium chloride intravenous bags, citing a labeling problem that could lead users to overdose on the IV solution, according to an FDA notice posted Friday.

The mislabeled Potassium Chloride Inj. 20 mEq bags contain an overwrap label with Lot# 1023172 (NDC# 0990-7074-26) and an expiration date of 01-31-2026. ICU Medical is recalling 1 lot of Potassium ...

What happenedShares of ICU Medical (NASDAQ: ICUI), a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock ...